Inhibition of STAT3-mediated glycolysis by bruceine D suppresses non-small-cell lung cancer progression &lt;i&gt;in vitro&lt;/i&gt; and &lt;i&gt;in vivo&lt;/i&gt;. This evidence concerns the gene STAT3 and non-small cell lung carcinoma.